Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humans is a research paper published in Communications Medicine (2025). On theSindex it has a DataRank of 0.416. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Health & Human Services | National Institutes of Health
Grant: R01AG046171, RF1AG051550, RF1AG057452, R01AG059093, RF1AG058942, U01AG061359, U19AG063744
Foundation for the National Institutes of Health
Grant: #DAOU16AMPA
National Institutes of Health
Grant: 5R01AG046171-03
Metabolic Networks and Pathways in Alzheimer's Disease
European Commission
Grant: 860197
Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis
National Health and Medical Research Council (NHMRC)
Grant: 1197190
Elucidating metabolic dysregulation in Alzheimer’s disease: Profiling the peripheral immune cell lipidome to unravel pathological mechanisms.
National Institutes of Health
Grant: 1UL1TR001420-01
Wake forest Clinical and Translational Science Award
National Institutes of Health
Grant: 5P30AG049638-03
Wake Forest Alzheimer's Disease Core Center
National Institutes of Health
Grant: 1RF1AG059093-01
Metabolic Networks and Pathways Predictive of Sex Differences in AD Risk and Responsiveness to Treatment
National Institutes of Health
Grant: 3RF1AG051550-01S1
Metabolic Signatures Underlying Vascular Risk Factors for Alzheimer-type Dementias
European Commission
Grant: 101053962
Fluid Biomarkers for Neurodegenerative Dementias
National Institutes of Health
Grant: 5R01AG069901-03
TargetAD: A systems multi-omics approach to drug repositioning in Alzheimer's disease
National Institutes of Health
Grant: 1RF1AG057452-01
Metabolic Network Analysis of Biochemical Trajectories in Alzheimer's Disease
National Institutes of Health
Grant: 1RF1AG058942-01
Gut Liver Brain Biochemical Axis in Alzheimer's Disease
National Institutes of Health
Grant: 3U01AG061359-05S1
Characterizing the AD Metabolome in Brain Tissue Samples of Individuals from Diverse Populations
National Institutes of Health
Grant: 5U19AG063744-02
Alzheimer's Gut Microbiome Project
NIA NIH HHS
Grant: R01 AG046171
NIA NIH HHS
Grant: U19 AG063744
NCATS NIH HHS
Grant: UL1 TR001420
NIA NIH HHS
Grant: RF1 AG059093
NIA NIH HHS
Grant: U01 AG061359
NIA NIH HHS
Grant: RF1 AG057452
NIA NIH HHS
Grant: P30 AG072947
NIA NIH HHS
Grant: R01 AG069901
NIA NIH HHS
Grant: P30 AG013319
NIA NIH HHS
Grant: P30 AG049638
NIA NIH HHS
Grant: RF1 AG058942
NIA NIH HHS
Grant: RF1 AG051550
FWCI
9.28
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals